Nutra Pharma Corp.
NPHC · OTC
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $6 | $7 | $8 | $15 |
| - Cash | -$0 | $0 | $0 | $0 |
| + Debt | $8 | $9 | $7 | $8 |
| Enterprise Value | $14 | $15 | $16 | $23 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 20.8% | 307.1% | -14.6% | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | 62.4% | 32.7% | 35.1% | -150.1% |
| EBITDA | $1 | -$0 | $5 | $2 |
| % Margin | 731.1% | -487.1% | 23,565.2% | 8,947.7% |
| Net Income | $1 | -$1 | $5 | $2 |
| % Margin | 528.6% | -935.5% | 22,585.2% | 8,346.6% |
| EPS Diluted | 0 | -0 | 0 | 0 |
| % Growth | 137% | -133.3% | 0% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |